 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
NIH, Research Groups Submit Dx, Biomarker IP to 'Patent Supermarket' for Non-Exclusive Licensing
October 03, 2012
NIH, Research Groups Submit Dx, Biomarker IP to 'Patent Supermarket' for Non-Exclusive Licensing
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Turning Pap Test into Sequencing-Based Gynecologic Cancer Assay will Take Further Validation
February 6, 2013 / Clinical Sequencing News - Hearing on Second-Opinion Genetic Testing Highlights Risks of Athena's Exclusive Licensing Practices
January 16, 2013 / Pharmacogenomics Reporter - Twin Study Sheds Light on Utility of Whole-Genome Sequencing for Common and Rare Diseases
April 4, 2012 / Clinical Sequencing News - Ahead of FDA Meeting on LDTs, Test Developers Prep for Increased Oversight, but Greater Clarity
July 7, 2010 / Pharmacogenomics Reporter - People in the News: Andy Page, David Lane, Mollie Roth
June 12, 2013 / Pharmacogenomics Reporter